Westport resident Scott Gottlieb, a physician and partner at one of the world’s largest venture capital funds and a former deputy commissioner at the U.S. Food and Drug Administration, is being considered by President-elect Donald Trump to run the agency, according to sources close to the transition team, the Reuters news agency reported.
Scott Gottlieb: reported on short list to head FDA. (CLICK TO ENLARGE) American Enterprise Institute photo
Gottlieb, 44, a venture partner at New Enterprise Associates and resident fellow at the American Enterprise Institute, a conservative think tank based in Washington, is well known in health policy circles and is a frequent commentator on television and in print.
Gottlieb, who purchased his Westport home in 2010, is a former internist at Stamford Hospital. He served as a deputy commissioner at the FDA from 2005 to 2007.
He is concurrently a clinical assistant professor at New York University School of Medicine and advises the U.S. Department of Health and Human Services as a member of the Federal Health IT Policy Committee.
Gottlieb has a medical degree from Mount Sinai School of Medicine and did his residency in internal medicine at the Mount Sinai Medical Center. He has a B.A. in economics from Wesleyan University.
He is being considered alongside Jim O’Neill, a self-declared libertarian and colleague of Peter Thiel, the co-founder of Mithril Capital Management who was an early Trump supporter and is now advising his transition team, the report said.
Bloomberg News first reported that Trump was looking at O’Neill.
